Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Ordinary Shares, $0.0001 par value
-
Shares outstanding
-
172,779,139
-
Total 13F shares
-
56,638,847
-
Share change
-
+1,976,064
-
Total reported value
-
$1,582,549,935
-
Put/Call ratio
-
68%
-
Price per share
-
$28.00
-
Number of holders
-
155
-
Value change
-
+$86,587,280
-
Number of buys
-
78
-
Number of sells
-
85
Institutional Holders of Structure Therapeutics Inc. - Ordinary Shares, $0.0001 par value (GPCR) as of Q3 2025
As of 30 Sep 2025 Structure Therapeutics Inc. - Ordinary Shares, $0.0001 par value (GPCR) had 155 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 56,638,847 shares of stock of the company.
Largest 10 holders included WELLINGTON MANAGEMENT GROUP LLP, FMR LLC, Avoro Capital Advisors LLC, JANUS HENDERSON GROUP PLC, Deep Track Capital, LP, BVF INC/IL, BAKER BROS. ADVISORS LP, Casdin Capital, LLC, RA CAPITAL MANAGEMENT, L.P., and MILLENNIUM MANAGEMENT LLC.
This table shows 155 institutional shareholders of the security as of 30 Sep 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.